Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis

Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis

By Giuseppe Fiorentino published in The Lancet September 9, 2021 below with analysis of the article & research by Chris Masterjohn, PhD below and commentary by Mark Bricca, ND "Based on an interim analysis recently published in a journal affiliated with...

read more
Swedish-Anglo Study in Turkey Reveals Metabolic Activators Reduce COVID-19 Duration by 3.5 Days—Now Submission for Approval in Turkey

Swedish-Anglo Study in Turkey Reveals Metabolic Activators Reduce COVID-19 Duration by 3.5 Days—Now Submission for Approval in Turkey

June 29, 2021 ~ TrialSite News ~ Swedish-Anglo Study in Turkey Reveals Metabolic Activators Reduce COVID-19 Duration by 3.5 Days—Now Submission for Approval in Turkey A group of Swedish, English and Turkish researchers found that the use of metabolic activators can...

read more
Vitamin D deficiency is associated with higher hospitalisation risk from COVID-19: a retrospective case-control study

Vitamin D deficiency is associated with higher hospitalisation risk from COVID-19: a retrospective case-control study

June 17, 2021 ~ J Clinical Endocrinology ~ Edward B Jude, et al. Vitamin D deficiency is associated with higher hospitalisation risk from COVID-19: a retrospective case-control study Link to Full Article: Vitamin D deficiency is associated with higher hospitalisation...

read more